Teva, Endo Curb Pay-For-Delay Pacts In $70M Deal With Calif.
Teva, Endo and a Japanese drugmaker will pay $70 million and put off inking pay-for-delay deals to end allegations that they illegally delayed cheaper alternatives to the narcolepsy drug Provigil and...To view the full article, register now.
Already a subscriber? Click here to view full article